RAPS is closely monitoring developments in the Coronavirus (COVID-19) outbreak. See our public safety page for the latest updates.

Regulatory Focus™ > News Articles > Botanical Products: Drugs and Dietary Supplements

Botanical Products: Drugs and Dietary Supplements

Posted 01 August 2009 | By

US regulations for botanical products that may be drugs can be confusing. In the author's experience, some botanicals that may have been processed and/or concentrated and have an indicated use for medical treatment are looked upon by the manufacturer as food supplements. Manufacturers take this position to avoid going through the rigors of the drug approval process. There are loopholes in the regulations that manufacturers try to use to eliminate this process.

Regulatory Focus newsletters

All the biggest regulatory news and happenings.

Subscribe

Regulatory Focus™ is doing essential, non-biased journalism during this unprecedented time. We appreciate your support as we bring you the news and intelligence you need to make an impact on global healthcare.

Regulatory Focus™ provides the intelligence you need to impact global healthcare during this crisis. Thank you for your support.